Recent Progress in Multiple Sclerosis and Migraine
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 74
Special Issue Editors
Interests: multiple sclerosis; stroke; COVID-19; clinical neurology; epilepsy
Special Issue Information
Dear Colleagues,
Multiple sclerosis (MS) and migraine are chronic and progressive neurological diseases that affect millions of people worldwide. Despite recent advancements in understanding the disease, there is still a need for continued research to improve diagnosis and treatment options. Diagnosis and assessment of MS and migraine, including imaging techniques, clinical diagnosis, and laboratory tests. We invite experts and professionals from various fields to submit original research articles and review papers related to multiple sclerosis and migraine. The scope of this journal edition will include but is not limited to
- Diagnosis and assessment of MS and migraine, including cerebrospinal fluid analysis, imaging techniques and clinical diagnosis;
- Novel and emerging therapies for MS and migraine, such as disease-modifying drugs and symptom management techniques;
- Multidisciplinary approaches to managing MS and migraine, including rehabilitation, psychological support, and lifestyle interventions.
Dr. Paolo Immovilli
Dr. Eugenia Rota
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical neurology
- multiple sclerosis
- migraine
- brain diseases
- epilepsy
- emerging diagnostics
- MRI
